RedHill Announces Positive Obesity and Diabetes Results with Opaganib August 19, 2024 / Obesity Treatment / Weight Loss Therapy / RedHill Biopharma RedHill Biopharma’s opaganib shows promising results in reducing weight gain and improving glucose tolerance in obesity and diabetes...

Using weight-for-age as a screening tool for metabolic syndrome in apparently healthy adolescents August 12, 2024 / Metabolic Syndrome / Screening / Weight-for-age / Adolescents / Early Detection This study found that weight-for-age percentiles effectively screen for metabolic syndrome (MetS)...

Pemvidutide seen to lower liver fat in MASLD patients in Phase 1 trial August 6, 2024 / MASLD Treatment / Metabolic Dysfunction / Clinical Trial Results Pemvidutide, an experimental therapy, significantly reduced liver fat, inflammation, and body weight in patients...

Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease July 26, 2024 / MASLD / Liver Disease Treatment A study identifies ferroptosis, an iron-catalyzed cell death, as a detrimental factor in metabolic dysfunction-associated steatotic liver disease (MASLD)....